Lexeo Therapeutics management to participate in September investor conferences
Lexeo Therapeutics said members of management will participate in investor conferences in September.
NEW YORK, Sept.
02, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc.
NASDAQ:LXEO a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that members of management will participate in the following investor conferences in Sept…